Report - TUMORI RARI: L’ESPERIENZA DELLA TOSCANA · terapia medica con inibitori RTK 2) Stretto monitoraggio con ... -Wang DB et al. “Neoadjuvantchemotherapy could improve survival outcomes

Please pass captcha verification before submit form